Vaccines, Blood & Biologics

TRETTEN

STN: 125398
Proper Name: Coagulation Factor XIII A-Subunit (Recombinant)
Tradename: TRETTEN
Manufacturer: Novo Nordisk Inc
Indication:

  • Is indicated for routine prophylaxis of bleeding in patients with congenital factor XIII A-Subunit deficiency.

Related Information

  • FDA Online Label Repository
    Search this database for drug labeling and other information. The content has not been altered or verified by the FDA and may not be the labeling on currently distributed products or identical to the labeling that is approved.

Resources for You

Page Last Updated: 12/23/2014
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English